相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections
Yu Lin Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Can Levofloxacin Be a Useful Alternative to Trimethoprim- Sulfamethoxazole for Treating Stenotrophomonas maltophilia Bacteremia?
Sun Young Cho et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Risk Factors and Outcomes of Stenotrophomonas maltophilia Bacteraemia: A Comparison with Bacteraemia Caused by Pseudomonas aeruginosa and Acinetobacter Species
Go Hotta et al.
PLOS ONE (2014)
Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review
M. Garazi et al.
JOURNAL OF HOSPITAL INFECTION (2012)
Stenotrophomonas maltophilia - The most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: A prospective multicenter study
Vincent Fihman et al.
JOURNAL OF INFECTION (2012)
Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009
H. Araoka et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Stenotrophomonas maltophilia: an emerging opportunist human pathogen
W. John Looney et al.
LANCET INFECTIOUS DISEASES (2009)
Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia
J. I. Garcia Paez et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Stenotrophomonas maltophilia:: Changing spectrum of a serious bacterial pathogen in patients with cancer
Amar Safdar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital
Gokhan Metan et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2006)
Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia
G Metan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model
BB Ba et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients:: A case-control study
A Apisarnthanarak et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Bacteraemia due to Stenotrophomonas maltophilia:: An analysis of 45 episodes
ND Friedman et al.
JOURNAL OF INFECTION (2002)
Serial evaluation of the SOFA score to predict outcome in critically ill patients
FL Ferreira et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: Role of severe neutropenia and mucositis
JA Labarca et al.
CLINICAL INFECTIOUS DISEASES (2000)
Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies
A Micozzi et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
